Home > Income Statement > CONCORD DRUGS

CONCORD DRUGS
Revenue

    Back to Income Statement
COMMUNITY POLL
for CONCORD DRUGS
Please provide your vote to see the results

CONCORD DRUGS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
Net Sales ₹45 Cr₹45 Cr₹52 Cr₹59 Cr

What is the latest Revenue of CONCORD DRUGS ?

The latest Revenue ratio of CONCORD DRUGS is ₹45 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹45 Cr
Mar2024₹45 Cr
Mar2023₹52 Cr
Mar2022₹59 Cr

How is Revenue of CONCORD DRUGS Trending?

Years Revenue % Change
Mar2025 ₹45 Cr
0.71
Mar2024 ₹45 Cr
-13.74
Mar2023 ₹52 Cr
-11.66
Mar2022 ₹59 Cr -

Compare Revenue of peers of CONCORD DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD DRUGS ₹92.1 Cr -2.6% 4.5% -17% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,228.0 Cr 1.2% 9.1% 6.6% Stock Analytics
DIVIS LABORATORIES ₹296,741.0 Cr -2.7% 22.2% 70% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,413.0 Cr -1% 2% 20.8% Stock Analytics
DR REDDYS LABORATORIES ₹116,771.0 Cr 1.5% 13% 12.1% Stock Analytics
CIPLA ₹114,397.0 Cr 1.7% 7.8% -7.3% Stock Analytics


CONCORD DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD DRUGS

-2.6%

4.5%

-17%

SENSEX

1.4%

12.4%

-1.7%


You may also like the below Video Courses